chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Narrative:  79yo male with the following problem list: PROBLEM LAST MOD PROVIDER Seen by palliative care medicine service (SCT 04/16/2021 305824005) (ICD-10-CM Z51.5), Onset 04/13/2021 Low vision left eye, normal vision right eye 02/05/2020 (SCT 334311000119108) (ICD-10-CM H54.52A1) Iron deficiency anemia (SCT 87522002) (ICD-10-CM 11/20/2019 D50.9) Obstructive sleep apnea of adult (SCT 09/06/2018 1101000119103) (ICD-10-CM G47.33) Chronic kidney disease stage 4 (SCT 431857002) 11/11/2016 (ICD-10-CM N18.4) GDS level 3 - mild cognitive decline (SCT 07/27/2016 407631005) (ICD-10-CM R41.9) Adjustment disorder with mixed emotional 02/09/2016 features (SCT 55668003) (ICD-10-CM F43.23) Secondary and unspecified malignant neoplasm of 11/19/2015 intra-abdominal lymph nodes (SCT 94347008) (ICD-10-CM C77.2) Diastolic heart failure (SCT 418304008) 07/05/2016 (ICD-10-CM I50.32), Onset 00/00/2015 Clostridium difficile infection (SCT 186431008) 09/29/2014 (ICD-9-CM 041.84), Onset 09/22/2014 Aldosterone deficiency (SCT 60086000) (ICD-9-CM 09/29/2014 255.5), Onset 09/22/2014 Renal tubular acidosis (SCT 1776003) (ICD-9-CM 09/29/2014 588.89), Onset 09/22/2014 POLYNEUROPATHY IN DIABETES (ICD-9-CM 357.2); 08/26/2010 Polyneuropathy in diabetes (ICD-9-CM 357.2/250.60) Type 2 diabetes mellitus without complications 11/20/2015 (SCT 313436004) (ICD-10-CM E11.9); Type 2 diabetes mellitus without complication (SNOMED CT 313436004) Hyperlipidemia, unspecified (SCT 55822004) 11/20/2015 (ICD-10-CM E78.5); Hyperlipidemia (SNOMED CT 55822004) Essential hypertension (SCT 59621000) (ICD-10-CM 11/20/2015 I10.) died at home on 11/19/2021. Pt had received covid vaccines on 3/17/21 & 4/15/21. This death is likely not related to the vaccinations due to patient's comorbidities, advanced age, and length of time from vaccine administration.
bronchitis; bad colds; sick with the flu; Initial information was received on 30-Nov-2020 regarding an unsolicited valid non-serious case from a consumer/non-health care professional (patient) .  This case involves a female patient (age unspecified) who had bronchitis, bad colds (nasopharyngitis) and was sick with the flu (influenza), while she received vaccine INFLUENZA VACCINE.  Medical history, medical treatment(s), vaccination(s), concomitant medications and family history were not provided.   On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer lot number not reported via unknown route in unknown administration site for prophylactic vaccination.  On an unknown date, the patient developed a non-serious bronchitis, bad colds (nasopharyngitis) and was sick with the flu (influenza) (unknown latency) following the administration of INFLUENZA VACCINE every year. She stopped taking the shots and hasn't been sick at all  No laboratory data was provided.  It was not reported if the patient received a corrective treatment.  At the time of report, the outcome of event was unknown.  There will be no information available on the batch number for this case.
My teenaged son experienced chest pain and shortness of breath following his second Pfizer COVID shot.  He felt he could not get a deep breathe for multiple days.
swelling of the lymph node on the side of her neck; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team.  A 47 year-old female patient received bnt162b2 (BNT162B2), administration date 14May2021 (Lot number: EW0179) at the age of 47 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2, for Covid-19 Immunisation. The following information was reported: LYMPHADENOPATHY (non-serious) with onset 15May2021, outcome "unknown", described as "swelling of the lymph node on the side of her neck". No follow-up attempts are possible. No further information is expected.
apperantly they received 3 shingrix so far; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of extra dose administered in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 3rd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced extra dose administered (Verbatim: apperantly they received 3 shingrix so far).  The outcome of the extra dose administered was unknown.   Additional Information: GSK Receipt Date: 13-SEP-2023 The reporter was working and a pateint walked in and apperantly they received 3 shingrix so far. The reporter consented to follow up. The provider had no information on the patient. The patient received 3rd dose of Shingrix, which led to extra dose administered.
Flu shot given approximately 8:15 AM, 10/22/05. By 6 PM, same evening, patient developed explosive, uncontrollable diarrhea lasting 5-6 days. On 11/08, patient began experiencing numbness, tingling in extremities. By 11/09, patient could no longer stand, walk. Went to ER; admitted to hospital. Diagnosed with GBS.  Information from discharge summary states gout, bone disorder  as additional symptoms. msv
Adverse reaction to Moderna Vaccine given to me on 5/6/2021. On 5/7/2021, I woke up with a painful red lump near the injection site. The pupils in both eyes were exceptionally large, almost as large as the green color/area of my eye.  As of this afternoon, my pupils are back to normal size, but the red lump on my arm has gotten bigger. I circled the area with a marker, & I am following PCP instructions.
Patient is a 75 y.o. male taking Eliquis with a history of atrial fibrillation, CAD, type II DM, and HTN who presents to the emergency department via EMS for evaluation of weakness. Per EMS, the patient reported increased weakness to his wife this morning around 8:30 AM. He appeared increasingly weak and confused throughout the day, prompting his wife to call emergency services. The patient was tachycardic and his blood pressure was 200/140 for EMS. He reported some chest pain and shortness of breath. He was brought into the stabilization room with concern for "EKG changes", per EMS. Blood sugar was 360. He was given one Nitro, 4 mg of Zofran, and 324 mg of Aspirin en route. Just prior to arrival to the ED, he became nauseas and vomited. Here, the patient reports that he developed left sided weakness today and has difficulty moving his left lower and upper extremities. He notes that he's had 3-4 days of sinus congestion, cough, and breathing difficulties He endorses abdominal pain and headache. He reports that he has been fully vaccinated against COVID.
Redness and lump at site of vaccinations. Redness and lump progressively worsened over the first 24 hours noticed about 5 hours after injections. Firm lump in area of vaccines approximately 1.5 inches circular. redness approximately 3 inches circular. In second 24 hours, redness expanded on 1 side of circle by approximately 1/2 inch. Significant discomfort in the arm at injection sites but I expected this. Checked this morning and it looks like the redness has stopped spreading and lump may be smaller. I have it marked to watch for worsening symptoms.
10/14, received third dose of vaxs. She ran a low grade fever of 101. Within 36 hours she began to have spasms sporadically. Consult with neurologist verified seizures and prescribed Klonapin as well as conducted tests which confirmed infantile spasms. These continued for 15 months. She continues to be delayed developmentally. She is now considered legally blind, she can not walk, sit, stand, talk or feed herself.
Severe swelling & bruising at site of injection - immediate burning & pain at site of injection - after couple of hours minor rash & itching near neck after a day. Right arm (FLUVIRIN) - TYLENOL and BENADRYL.
Was diagnosed with Polymyalgia Rheumatica in June 2021. Severe bilateral shoulder and hip pain with weight loss. Symptoms controlled with prednisone; on steroids for at least 6 months.
Patient is fully vaccinated with 2 doses of Pfizer and was hospitalized with COVID-19 pneumonia on 12/14/21
presented with hives across chest and on other arm / hives on arm of injection; itch; This case was reported by a nurse via sales rep and described the occurrence of hives in a adult male patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix at an unknown dose. On an unknown date, less than a day after receiving Shingrix, the patient experienced hives. The patient was treated with prednisone. On an unknown date, the outcome of the hives was unknown.   It was unknown if the reporter considered the hives to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The age group of the patient was not reported, but selected as an adult as per vaccine indication. The patient received dose of Shingrix in the evening at around 7:30 to 8pm at local pharmacy. The reporter stated that, following morning (friday) after vaccination, the patient experiened hives on the arm  of injection, across chest, and on other arm and it was progresively worse. The patient had traveled 3 days prior to receiving Shingrix. The patient complained of the hives being mostly bothersome. The patient has not been seen back in the office and had no shortness of breath or tongue issues. The reporter consented to follow up.   Follow up information received from nurse on 23rd April 2020: The patient's demographic details were updated. The patient did not have any additional medical history. The patient had not perform laboratory testing. The patient received Prednisine 20 miligram, Benadryl 25 miligram, and Triamunoline cream as a treatment medication. The reporter stated that, the patient was recovering from hives. The reporter considered, the hives and itch was almost certain related to Shingrix. The reporter stated that, the patient received vaccine at pharmacy and not at office.
Expired dose administered; This case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 11-year-old female patient who received Men B NVS (Bexsero) (batch number ABXB835AA, expiry date 31st July 2022) for prophylaxis.   Co-suspect products included meningococcal B recom vaccine + aloh + omv pre-filled syringe device (Bexsero Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 2nd August 2022, the patient received Bexsero and Bexsero Pre-Filled Syringe Device. On 2nd August 2022, unknown after receiving Bexsero and Bexsero Pre-Filled Syringe Device, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown.     This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 03-AUG-2022 Reporter's Comments: The office manager called in to report an expired Bexsero dose was inadvertently administered to a patient. No other details provided. The reporter consented to follow up. Additional Supportive Information: The administration of expired dose of Bexsero to the patient, dose was expired since 31st July 2022, which led to expired vaccine used.
Received H1N1 FLUMIST #1 and second Flu shot 10/22/09. 2 days later redness noted on his stomach, spreading to the hand and legs, no fever, no respiratory distress: persisted still 11/5/09 (3 days after treated with BENADRYL).
patient got pneumonia and was tested positive for covid; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 PNEUMONIA (patient got pneumonia and was tested positive for covid) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Overweight.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced COVID-19 PNEUMONIA (patient got pneumonia and was tested positive for covid) (seriousness criterion hospitalization). At the time of the report, COVID-19 PNEUMONIA (patient got pneumonia and was tested positive for covid) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In 2021, Coronavirus test: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. No treatment related information has been reported.  She went to get the Moderna vaccine about 3 weeks ago.  About 4 days after her shot, she got pneumonia.  She was rushed to the hospital.
Breakthrough case admission after 2 vaccines moderna 2/8/21 lot# 013M20A;  Moderna 3/8/21 lot# 030A21A
his son has been having migraine for 6 months now since he had the Moderna Covid-19 vaccine.; This spontaneous case was reported by a patient family member or friend and describes the occurrence of MIGRAINE (his son has been having migraine for 6 months now since he had the Moderna Covid-19 vaccine.) in a male patient of an unknown age who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced MIGRAINE (his son has been having migraine for 6 months now since he had the Moderna Covid-19 vaccine.). At the time of the report, MIGRAINE (his son has been having migraine for 6 months now since he had the Moderna Covid-19 vaccine.) had not resolved.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter did not provide any causality assessments.   No Concomitant medications were provided.  Caller reported that his son has been having migraine for 6 months nowsince he had the Moderna Covid-19 vaccine. His migraine was 8/10 and has not gone to school for 5 months now. He has also been missing games which he was very good at.   No treatment medications were provided.
After administration of IM shot to Right Arm, the Patient became faint after seeing blood dripping down arm from injection site. While I was applying a cotton ball and pressure to site, the patient stated being light headed and passed out (head fell back while still in chair) for 10 seconds or so. Patient became aware and immediately Grand Mal Seized (head rolled back and bobbed, body stiffened and whole body shook while she was seated in the chair. The Seizure lasted 10-15 seconds. Patient became awake and asked what just happened. Emergency Response was activated (911 was called). Patient remained lighted headed and dizzy (but did not pass out or seize) up until Emergency Squad arrived at scene (within 10 - 15 minutes). To prevent patient from passing out again, I had her lie on the floor with her feet up during the time we waited on the Emergency Squad. She was taken by ambulance to the local hospital.
pt brought to hospital from home with cough and fevers; found to be positive for COVID 9/10/22; DNR/DNI; pursuing outpatient hospice already; given Remdesivir, O2 supplementation; dc'd to home 9/19/22 with hospice (name of company not in medical records); pt passed away in his home
Vaccine was administered in the left outer upper arm area by MA while mom was in the room.  Patient was sitting on the exam table.  As she left the room mom shouted and when I entered the room patient had fallen to the ground forward and lost consciousness for a brief period (2-3 seconds) and slowly regained the color and consciousness.  No vomiting or any seizure and observed in the office and he wanted to go home after 30 minutes.  On examination noted to have a small bump on the right fore head and bruise on his left knee.  Pupils were equal and reactive and no headache or any focal signs.  He felt OK and wanted to go home and left the office just after 4 PM.  Mom was advised to take him to ER if any headache, seizures, vomiting or any focal signs or any concerns.   I called to check on him on 10/23/19: he went to school and had a short day till 11 AM.  Mild headache and left knee pain persists but improving with Tylenol and ice application.  Mom was again requested to take him to ER for evaluation is she has any concerns.  Likely he had a vaso-vagal incident.
Approx 30 min p/vax, mom appeared back in clinic noting devel rash on pts face & body; pt referred to peds clinic, seen by MD papular rash noted; no wheezing, swelling of throat noted;
Very painful arm at the injection site. Dizziness for 12-24 hours, Chest pain, felt very tight in my chest, like my heart was hurting. General fatigue. Mainly wanted to make it known that my heart was hurting after the shot. I have never had any heart issues ever before.
Not feeling well; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) from medical information team for a Pfizer sponsored program (159558). The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: MALAISE (non-serious), outcome "unknown", described as "Not feeling well".  Additional information: The patient had a question concerning how, for the second dose if the patient was not feeling well, should take the second dose and what if the second dose cannot be provided on 21 days. The patient had a question, if not feeling well should take the second dose.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Red lesion on arm. Approx 2 inches in diameter. Started off as a pale pink. 8 days later it is bright red. Slightly elevated.
Patient is a 85 y.o. female patient of DO with history of diabetes, hypothyroidism, hypertension, Lewy body dementia complicated with behavioral changes, rheumatoid arthritis, tuberculosis, Guillain-Barré syndrome,Who was brought by family for progressive dementia, agitation and possible placement.     Per ED, patient brought by family for placement, noted to have aggressive behavior and hallucinations, she was supposed to move to assisted living but they are unable to take her due to agitation.     Lewy body dementia with behavioral changes and hallucinations, improved Resume home Seroquel. Lexapro Donepezil ED placed consult for psychiatry, appreciate input No haldol per son, had bad reaction to it   Continue on Seroquel 25 in the morning and 50 in the afternoon.  Patient remains easily redirectable.   Presyncope Hypertension Orthostatic hypotension. Home blood pressure medications held (Coreg, amlodipine, hydrochlorothiazide) Midodrine was started and then discontinued. Likely problem is autonomic dysfunction.  She does not look clinically hypovolemic but I have to maintain hydration with her. Strict compression stockings bilaterally. Resume Norvasc at discharge per Discontinue hydrochlorothiazide and Coreg as it can exacerbate orthostasis. Patient's son was educated about issue, patient would have to slowly get out of bed and stand up, be careful with changing position. Nursing facility to be made aware.   Acute hypoxemic respiratory failure, resolved Pneumonia secondary to COVID, resolved Community-acquired pneumonia in the left lower lobe, resolved Chest x-ray noted left lower lobe airspace disease with mild left pleural effusion Status post antibiotics and steroids.   Covid-19 Virus Infection, resolved Date of covid positive test: 12/19/22 Oxygen requirements on admission: 2 L Current oxygen requirements: 2 L Medical therapy: steroids, remdesivir is done Anticipated special isolation end date: 12/29/22    Urinary tract infection, resolved Urine cultures are not significant, stop ceftriaxone   Rheumatoid arthritis, continue hydroxychloroquine
11 days p/ vax pt devel a mild rash w/less than 50 lesions
woke up the morning after my vaccine around 8am and immediately noticed generalized deep soreness at the corner of my left eye, slightly behind the eye (pain does not extend to the temple). I pressed on the area to feel for lumps but found none. I also closely inspected the lash line to check for stye development, but again saw nothing. When pressing on my eye or squinching my eyes shut, pain increases)
the morning after the injection arm became red and hot and that same night small pimple like bumps appeared on arm
Felt dizzy, had metallic taste in mouth.  Numbness & tingling of lips, tip of tongue.  Dizzyness got better after 15 minutes.  Tingling of lips & tongue better after 1 hour, but still present.  Face felt hot & flushed 40 minutes after shot.  Also had some "burning" of veins in wrist .  Metallic taste continues..  Some itching of face.
Reactivation Of Epstein Barr Virus; Trouble swallowing; Tongue Painful; Eyes running; Eyes yellow matter; Extremely Fatigue; Low grade Fever; This spontaneous case was reported by a patient family member or friend and describes the occurrence of EPSTEIN-BARR VIRUS INFECTION REACTIVATION (Reactivation Of Epstein Barr Virus) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Infectious mononucleosis (has history of Infectious Mononucleosis 2 times).    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced EPSTEIN-BARR VIRUS INFECTION REACTIVATION (Reactivation Of Epstein Barr Virus) (seriousness criterion medically significant), DYSPHAGIA (Trouble swallowing), GLOSSODYNIA (Tongue Painful), LACRIMATION INCREASED (Eyes running), EYE DISCHARGE (Eyes yellow matter), FATIGUE (Extremely Fatigue) and PYREXIA (Low grade Fever). At the time of the report, EPSTEIN-BARR VIRUS INFECTION REACTIVATION (Reactivation Of Epstein Barr Virus), DYSPHAGIA (Trouble swallowing), GLOSSODYNIA (Tongue Painful), LACRIMATION INCREASED (Eyes running), EYE DISCHARGE (Eyes yellow matter), FATIGUE (Extremely Fatigue) and PYREXIA (Low grade Fever) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In 2021, SARS-CoV-2 test: negative (Negative) negative. In 2021, Streptococcus test: negative (Negative) negative.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment for the events included antibiotics and eye drops.  EBV can be reactivated as a result of with weakened immune systems manifesting in patients developing symptoms.  Hence, based on the information provided and the onsets of the reported events, a causal association cannot be excluded. Fatigue and fever are consistent with the known safety profile of mRNA-1273; Sender's Comments: EBV can be reactivated as a result of with weakened immune systems manifesting in patients developing symptoms.  Hence, based on the information provided and the onsets of the reported events, a causal association cannot be excluded. Fatigue and fever are consistent with the known safety profile of mRNA-1273
Pt had chest pain 24 hours after administration of 2nd dose of Pfizer vaccine
1) Pain at injection site and swollen lymph node in days immediately following vaccination 2) Random itchiness in both time and place on body. No visible redness, hives, etc. UNTIL scratching, then puffy wheals, visibly red, and warm to touch. Onset two weeks after vaccination and still continuing two weeks after onset
Systemic: Dizziness / Lightheadness-Medium, Systemic: Fainting / Unresponsive-Medium, Systemic: Flushed / Sweating-Mild